ACRO's advisory council chimes in on Big Pharma's R&D supergroup

The Association of Clinical Research Organizations (ACRO) assembled a group of CRO leaders to advise TransCelerate BioPharma, a nonprofit group run by the biggest names in drug development. At its inaugural meeting, the CRO Forum appointed executives from Quintiles ($Q) and INC Research ($INCR) to its leadership posts and picked senior subject matter experts to advise TransCelerate on its efforts to implement risk-based monitoring, site qualification, common protocols and shared quality-management systems. More

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.